Minerva Surgical, Inc.
UTRS
Rank in Stocks
#35008
Minerva Surgical, Inc. functions as a commercial-stage medical technology... Minerva Surgical, Inc. functions as a commercial-stage medical technology enterprise, specializing in the creation, production, and distribution of innovative, minimally invasive solutions tailored to address the uterine healthcare needs of women throughout the United States. Their suite of offerings features advanced endometrial ablation systems, including the Minerva ES and Genesys HTA. They also provide the Symphion Tissue Removal System, a sophisticated, minimally invasive device for uterine tissue removal that uniquely integrates bladeless tissue resection, coagulation capabilities, continuous visualization during procedures, and precise intrauterine pressure monitoring. Additionally, the Resectr Tissue Resection Device is a handheld surgical tool engineered for the hysteroscopic removal and diagnostic evaluation of endometrial polyps. These specialized instruments are utilized by obstetrician-gynecologists across a variety of clinical settings, such as hospitals, outpatient ambulatory surgical centers, and private physician practices. The company was founded in 2008 and is headquartered in Santa Clara, California.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$887.30
Change (1 day)
0.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Minerva Surgical, Inc. (UTRS)
Category
Healthcare
Operating Margin for Minerva Surgical, Inc. (UTRS)
Operating Margin as of November 2026 TTM: -61.44%
According to Minerva Surgical, Inc.'s latest financial reports, its current operating margin (TTM) is -61.44%. At the end of 2022 the company had an operating margin of -61.44%.
Operating Margin history for Minerva Surgical, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -61.44% | 0.00% |
| 2022 | -61.44% | 9.83% |
| 2021 | -55.94% | 37.28% |
| 2020 | -40.75% | -46.02% |
| 2019 | -75.49% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 13.21% | -100.22% |
US
|
|
| 3.61% | -100.06% |
US
|
|
| -19.76% | -99.68% |
US
|
|
| 74.94% | -101.22% |
AU
|
|
| 13.01% | -100.21% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Minerva Surgical, Inc.'s operating margin
What is Minerva Surgical, Inc.'s operating margin?
Minerva Surgical, Inc.'s operating margin is -61.44%, as of Nov 2026.
What was Minerva Surgical, Inc.'s operating margin in 2022?
In 2022, Minerva Surgical, Inc.'s operating margin was -61.44%, compared with -55.94% in 2021.
How has Minerva Surgical, Inc.'s operating margin changed since 2019?
From 2019 to 2022, Minerva Surgical, Inc.'s operating margin was highest in 2020 (-40.75%) and lowest in 2019 (-75.49%).
How does Minerva Surgical, Inc.'s operating margin compare with similar companies?
Minerva Surgical, Inc.'s operating margin (-61.44%) is lower than that of all 5 similar companies listed above. The highest among them is Pro Medicus Limited, with 74.94%.